Friday, February 28, 2014
Tuesday, February 25, 2014
[update::02014.02.26] 30 minutes into trading today and ALTI is up 12% of heavy volume (487,000 vs. 33,100). ALTI is at $6.53 after hitting an intra-day early morning high of $6.94. If there's news (and I suspect there is), I'm not aware of it.
[update::02014.02.27] ALTI closed yesterday (02014.02.26) at $5.98, up only 2.57%. Intra-day high was $6.98. Volume was 770,889, which according to the information I see on Yahoo! Finance is ~16% of the float. Again, if there's news, I don't know that it is.
Monday, February 24, 2014
This morning Illumia issued a press release that started with the following paragraph.
Science for Life Laboratory (SciLifeLab) in Sweden has joined the Illumina Genome Network (IGN) to provide researchers with broader access to Illumina’s whole genome sequencing technology. SciLifeLab is the first IGN partner in Europe and will initiate a national large-scale population sequencing program seeking to identify genetic causes of human diseases.
Friday, February 21, 2014
At $10.18 our GKNT investment will be underwater. The question I'm asking myself right now: At what price might be a good price to buy some GKNT?
[update::02014.02.22] GKNT closed yesterday (02014.02.21) at $14.47, which means the company lost ~16% of its market value. Volume was 225,449; however, GKNT is a thinly traded stock that had a trailing-3-month average of 11,974. Approximately 3% of GKNT shares were traded.
Thursday, February 20, 2014
Bruker (BRKR) get a 'Sell' rating by Zacks Equity Research. Zachs.com has a posting headlined: Can Bruker (BRKR) Continue to Rise? My response: Yes... as long as scientists keep doing science.
Geeknet (GKNT) is reporting 4Q'13 results tomorrow (02014.02.21) morning. It bothers me that the company has taken so long to report year end results for 02013. The company has been quiet with respect to ThinkGeek's holiday sales.
Wednesday, February 19, 2014
Looking ahead to 2014, we feel better about the health of our core academic and government customers and about our prospects in the clinical research and diagnostics markets, but we remain cautious about demand from the industrial markets. Overall, we expect to generate year-over-year revenue growth of approximately 3 to 4 percent, and non-GAAP EPS growth of 10 to 14 percent, for the full year 2014.BRKR closed yesterday (02014.02.18) at $21.86. 52-week range: $15.41 - $22.25. At its current price BRKR has a PSR (Price Sales Ratio) of 2, which I think is low for a company that makes equipment that scientists use to create our future.
Five minutes into trading today (02014.02.19) BRKR is at $23.25 (up ~6.4%) after spiking to a new 52-week high of $23.59.
Tuesday, February 18, 2014
I need my head examined, but I bought some VeriTeQ (VTEQ) today (02014.01.10) at $0.83. Just a few days ago VTEQ was a $2 stock. Back on 22 October 02013 VeriTeQ (formerly Digital Angel [DIGA]) executed a 1:30 (reverse) stock split.
Today, 02014.01.18, VTEQ closed at $1.39, up 33.65%. 52-week range: $0.60 - $4.30. The company issued a press release having the following headline: VeriTeQ Partner Establishment Labs Receives Additional CE Mark Approvals to Market Breast Implants with Q Inside Safety Technology. The sub-headline was: New CE Mark Approvals Permit the Sale of Motiva Implants with Q Inside Safety Technology to 28 Countries in the European Union
I've always found RFID an interesting technology.
VeriTeQ develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ offers the world's first FDA cleared RFID microchip technology that can be used to identify implantable medical devices, in vivo, on demand, at the point of care.
VTEQ is a crap shoot.
Friday, February 14, 2014
"We had a great year in 2013, led by strong growth in both supercomputing and big data," said Peter Ungaro, president and CEO of Cray. "We set Company records for annual and quarterly revenue as we completed the acceptance of more supercomputers during the fourth quarter than we have in any quarter in our history.
Thursday, February 13, 2014
Today (02014.02.13), prior to the markets opening, I saw this news: Nanosphere upgraded to Buy from Neutral at Roth Capital Roth Capital upgraded Nanosphere citing improved revenue and placement visibility following the company's Q4 results. Roth raised its price target for shares to $3 from $2.50.
NSPH is a speculative investment. From Nanosphere's 4Q'13 press release: Cash flow for the fourth quarter of 2013 was negative $7.8 million as compared with negative $8.8 million in the same quarter of 2012. Cash at December 31, 2013 was $41.5 million. Since 02011 the number of NSPH common shares outstanding has increased to ~62,134,000 from ~37,800,000.
Wednesday, February 12, 2014
"While the fourth quarter supports the anticipation of an improved organic growth outlook for 2014, the environment continues to be comparatively uncertain with variations of regional economic performance, continuing deferrals of investment, and continued constrained government funding."
Tuesday, February 11, 2014
At $21.74, BRKR has a PSR (Price Sales Ratio) of 2, which I think is low given Bruker is the maker of scientific equipment that is helping researchers create our future.
Saturday, February 8, 2014
GOOG closed yesterday (02014.02.07) at $1177.44. 52-week range: $761.26 - $1186.54.
Thursday, February 6, 2014
Wednesday, February 5, 2014
Twitter's revenue for 02013 was $665 million. The company is projecting 02014 revenues of $1.15 billion to $1.2 billion.
Twitter ended 02013 with approximately $2.2 billion in "cash."
TWTR closed today (02014.02.05) at $65.97. 52-week range: $38.80 - $74.73.
[update::02014.02.06] Ouch! TWTR opened down 23.28%. Previous close $65.97; opened at $50.61. Dipped to $50.00 and right now (35 minutes into trading) its down 19% at $53.35.
LVLT had a gap open today (02014.02.05). Previous close was $31.41 and the open was at $32.59. LVLT spiked to a new 52-week high $34.83 during the first few minutes of trading.
Monday, February 3, 2014
KTOS closed Friday, 02014.01.31, at $7.23. 52-week range: $4.08 - $9.16.
[update::02014.02.03] Markets opened while I was typing this in. Two minutes into trading and KTOS was at $9.02 (up 24.70%).